Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Kidney Int. 2013 Sep 25;85(1):10.1038/ki.2013.378. doi: 10.1038/ki.2013.378

Table 1.

Grading of evidence

Level 1 ‘We recommend’ Most patients should receive the recommended course of action
Level 2 ‘We suggest’ Different choices will be appropriate for different patients. Each patient needs help to arrive at a management decision
consistent with her or his values and preferences
Grade A high quality Evidence obtained from at least one properly designed randomized controlled trial
Grade B good quality Evidence obtained from well-designed controlled trials without randomization
Grade C moderate quality Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or
research group
Grade D poor quality Evidence obtained from multiple time series with or without the intervention and uncontrolled trials